InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+0.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Shafer Bradford J, Directeur Exécutif. Director active across 1 company, notably Theravance Biopharma, Inc.. Cumulatively, 4 reports have been recorded. History available since 20 May 2021. The latest transaction was filed on 20 August 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
4,307 shares@ US$14.050.0062% mcap22.6% of flowOrdinary SharesSEC:0001179110-21-008402:0
4,307 shares@ US$14.0522.6% of flowOrdinary SharesSEC:0001179110-21-008402
4,310 shares@ US$17.8027.4% of flowOrdinary SharesSEC:0001179110-21-005850
4,310 shares@ US$17.800.0075% mcap27.4% of flowOrdinary SharesSEC:0001179110-21-005850:0
4 of 4 declarations
About Shafer Bradford J
Bradford J. Shafer serves as Executive Vice President, General Counsel, and Secretary at Theravance Biopharma, Inc. He oversees the legal affairs and compliance of the company, which focuses on drug development. Bradford J. Shafer plays a key role in managing legal risks and protecting the company's interests.
